Rankings
▼
Calendar
HRMY FY 2018 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$184,000
Operating Income
-$41M
Net Income
-$40M
EPS (Diluted)
$-1.42
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$40M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$89M
Total Liabilities
$8M
Stockholders' Equity
$82M
Cash & Equivalents
$84M
← Q1 2019
All Quarters